![](/images/Email.png)
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,G810R](Homo sapiens (Human))
Eli Lilly
US Patent
Eli Lilly
US Patent
Affinity DataIC50: 58.7nMAssay Description:The potency of a compound inhibiting G81 OR mutant RET kinase was determined using CisBio's HTRF Kinease-TK assay technology. The assays containe...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)